High rates of macrolide and fluoroquinolone resistance in human campylobacteriosis in the Middle East and North Africa
Dabbousi A, Osman M, Dabboussi F, Hamze M. High rates of macrolide and fluoroquinolone resistance in human campylobacteriosis in the Middle East and North Africa. Future Microbiology 2022, 17: 957-967. PMID: 35796073, DOI: 10.2217/fmb-2021-0302.Peer-Reviewed Original ResearchConceptsHuman campylobacteriosisRoutine stool cultureBacterial gastrointestinal infectionsClinical laboratoriesIncidence of campylobacteriosisPaucity of dataMain causative agentStool culturesGastrointestinal infectionsDiarrheal patientsMicrobiological diagnosisClinical importanceFluoroquinolone resistanceInfection prevalenceAntimicrobial resistanceZoonotic diseaseCausative agentCampylobacteriosisHigh rateAlarming ratePatientsCritical needEpidemiologyInfectionPrevalenceGenome sequence of a multidrug-resistant Campylobacter coli strain isolated from a newborn with severe diarrhea in Lebanon
Halimeh F, Rafei R, Diene S, Osman M, Kassem I, Jamal Akoum R, Moudani W, Hamze M, Rolain J. Genome sequence of a multidrug-resistant Campylobacter coli strain isolated from a newborn with severe diarrhea in Lebanon. Folia Microbiologica 2022, 67: 319-328. PMID: 34997523, DOI: 10.1007/s12223-021-00921-w.Peer-Reviewed Original ResearchConceptsCampylobacter coli strainsSevere diarrheaST-828 complexC. coli isolatesBurden of CampylobacterBeta-lactam resistanceNew sequence typesSequencing analysisEpidemiological backgroundColi isolatesWhole-genome sequencing analysisAminoglycoside resistanceC. coliColi strainsAntimicrobial resistanceBlaOXA-61Virulence determinantsDisk diffusionMLST analysisWGS analysisDiarrheaNewbornsPTet plasmidAntimicrobial susceptibility phenotypesSusceptibility phenotype